title: Statinopause.
abstract: Statins are the cornerstone of lipid-lowering therapy for cardiovascular disease prevention. The 2013 American College of Cardiology (ACC) and American Heart Association (AHA) guidelines represent a fundamental shift in how statins will be prescribed. The new guidelines recommend statins for nearly all older patients up to age 75 years, including healthy adults with low normal lipid levels and no atherosclerotic cardiovascular disease (ASCVD) risk factors other than age. Under the 2013 guidelines, age becomes a main determinant for initiating statin therapy for primary prevention among older adults. Specifically, according to the new guidelines, white males aged 63-75, white females aged 71-75, African American males aged 66-75, and African American females aged 70-75 with optimal risk factors would be recommended for statin treatment for primary prevention. Based on the new guidelines, one could term these older adults as having "statin deficiency," a condition warranting statin treatment. We call this putative condition of age-related statin deficiency "statinopause." After careful examination of the trial evidence, we find very little support for the new recommendations for primary prevention. The lack of evidence underscores the need for clinical trials to determine the risks and benefits of statin therapy for primary prevention among older adults.
authors.affiliation: Division of Geriatric Medicine and Palliative Care, Department of Medicine, New York University School of Medicine, 550 1st Ave, New York, NY, 10016, USA, Benjamin.han@nyumc.org.
authors.forename: Benjamin H
authors.initials: BH
authors.lastname: Han
authors.forename: Yitzchak
authors.initials: Y
authors.lastname: Weinberger
authors.forename: David
authors.initials: D
authors.lastname: Sutin
mesh_terms: D000367:Age Factors; D000368:Aged; D002318:Cardiovascular Diseases / Q000517:prevention & control*; D011307:Drug Prescriptions / Q000592:standards; D005260:Female; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D017410:Practice Guidelines as Topic; D011322:Primary Prevention / Q000379:methods / Q000592:standards; D018570:Risk Assessment / Q000379:methods
chemical_list: D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors
references.citation: Ann Intern Med. 1998 Nov 1;129(9):681-9
references.pmid: 9841599
references.citation: J Am Geriatr Soc. 2014 May;62(5):943-5
references.pmid: 24800984
references.citation: BMJ. 2013 Nov 21;347:f6989
references.pmid: 24264770
references.citation: Age Ageing. 2011 Nov;40(6):659-65
references.pmid: 21911335
references.citation: Arch Intern Med. 2008 Jan 28;168(2):136-40
references.pmid: 18227358
references.citation: Lancet. 2003 Apr 5;361(9364):1149-58
references.pmid: 12686036
references.citation: JAMA. 1998 May 27;279(20):1615-22
references.pmid: 9613910
references.citation: PLoS One. 2011;6(10):e25987
references.pmid: 22028802
references.citation: Lancet. 2013 Nov 30;382(9907):1762-5
references.pmid: 24268611
references.citation: JAMA. 2011 Jun 22;305(24):2556-64
references.pmid: 21693744
references.citation: J Gen Intern Med. 2011 Jul;26(7):783-90
references.pmid: 21286840
references.citation: Am J Cardiovasc Drugs. 2008;8(6):373-418
references.pmid: 19159124
references.citation: Ann Intern Med. 2010 Apr 20;152(8):488-96, W174
references.pmid: 20404379
references.citation: JAMA. 2014 Feb 5;311(5):463-4
references.pmid: 24296612
references.citation: Cochrane Database Syst Rev. 2013 Jan 31;(1):CD004816
references.pmid: 23440795
references.citation: N Engl J Med. 2008 Nov 20;359(21):2195-207
references.pmid: 18997196
references.citation: J Am Geriatr Soc. 2012 Oct;60(10):E1-E25
references.pmid: 22994865
references.citation: Drug Saf. 2007;30(3):195-201
references.pmid: 17343428
references.citation: Lancet. 2012 Aug 11;380(9841):581-90
references.pmid: 22607822
references.citation: J Clin Oncol. 2003 Apr 1;21(7):1383-9
references.pmid: 12663731
references.citation: Circulation. 1997 Dec 16;96(12):4211-8
references.pmid: 9416884
references.citation: Cochrane Database Syst Rev. 2011 Jan 19;(1):CD004816
references.pmid: 21249663
references.citation: BMJ. 2010 May 20;340:c2197
references.pmid: 20488911
references.citation: Lancet. 2002 Nov 23;360(9346):1623-30
references.pmid: 12457784
references.citation: J Am Coll Cardiol. 2014 Jul 1;63(25 Pt B):2889-934
references.pmid: 24239923
references.citation: N Engl J Med. 2014 Apr 10;370(15):1422-31
references.pmid: 24645848
references.citation: J Am Geriatr Soc. 2014 May;62(5):945-7
references.pmid: 24801130
references.citation: Lancet. 2011 Dec 10;378(9808):2013-2020
references.pmid: 22115874
references.citation: Ann Intern Med. 2001 May 15;134(10):931-40
references.pmid: 11352694
references.citation: N Engl J Med. 1995 Nov 16;333(20):1301-7
references.pmid: 7566020
references.citation: Lancet. 2006 Sep 30;368(9542):1155-63
references.pmid: 17011942
references.citation: Lancet. 2004 Aug 21-27;364(9435):685-96
references.pmid: 15325833